{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T13:39:31Z","timestamp":1788788371924,"version":"build-2803163510"},"reference-count":13,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,10,8]],"date-time":"2021-10-08T00:00:00Z","timestamp":1633651200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,10,8]],"date-time":"2021-10-08T00:00:00Z","timestamp":1633651200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Med Case Reports"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Minoxidil hair formulation is commonly used for the treatment of male or female androgenic alopecia. This over-the-counter product is considered safe, but should be used with caution. Ocular side effects following topical minoxidil use are rarely reported. In this paper, we report a rare case of inferior hemiretinal artery occlusion possibly caused by topical 5% minoxidil treatment.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Case description<\/jats:title>\n                <jats:p>A 21-year-old Asian Indian male presented to the retina clinic with sudden onset blurring of vision and superior visual field loss in the right eye since morning. He was diagnosed with androgenic alopecia and was on treatment with topical 5% minoxidil spray twice a day for the last 3\u00a0years. On examination, his corrected distance visual acuity was 6\/6, N6 in both eyes. Anterior segment examination and intraocular pressure in both eyes and left eye fundus were within normal limits. Right eye fundus examination showed features suggestive of inferior hemiretinal artery occlusion, which were confirmed on fluorescein angiography and optical coherence tomography. A detailed systemic evaluation and investigations (blood pressure, random blood sugar, hematological and coagulation profile, serum homocysteine level, Mantoux test, chest x-ray, cardiac two-dimensional echography, thyroid function test, and immunological profile) did not detect any abnormalities. The ocular condition and its visual prognosis were explained to the patient, and he was asked to review after 4\u00a0weeks.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Though there is no definite cause\u2013outcome relationship between topical minoxidil use and retinal artery occlusion development, this possibility should be kept in mind when observing retinal vascular occlusion cases with concurrent use of topical minoxidil.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13256-021-03114-8","type":"journal-article","created":{"date-parts":[[2021,10,7]],"date-time":"2021-10-07T23:31:52Z","timestamp":1633649512000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Retinal artery occlusion as a probable idiosyncratic reaction to topical minoxidil: a case report"],"prefix":"10.1186","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4479-9390","authenticated-orcid":false,"given":"Ramesh","family":"Venkatesh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arpitha","family":"Pereira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikitha Gurram","family":"Reddy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naresh Kumar","family":"Yadav","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,10,8]]},"reference":[{"issue":"1","key":"3114_CR1","doi-asserted-by":"publisher","first-page":"61","DOI":"10.7326\/0003-4819-94-1-61","volume":"94","author":"SL Linas","year":"1981","unstructured":"Linas SL, Nies AS. Minoxidil. Ann Intern Med. 1981;94(1):61\u20135.","journal-title":"Ann Intern Med"},{"issue":"2","key":"3114_CR2","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1111\/j.1365-2133.2004.05785.x","volume":"150","author":"AG Messenger","year":"2004","unstructured":"Messenger AG, Rundegren J. Minoxidil: mechanisms of action on hair growth. Br J Dermatol. 2004;150(2):186\u201394.","journal-title":"Br J Dermatol"},{"issue":"4","key":"3114_CR3","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1111\/j.1365-2125.1988.tb03410.x","volume":"26","author":"FH Leenen","year":"1988","unstructured":"Leenen FH, Smith DL, Unger WP. Topical minoxidil: cardiac effects in bald man. Br J Clin Pharmacol. 1988;26(4):481\u20135.","journal-title":"Br J Clin Pharmacol"},{"issue":"2","key":"3114_CR4","doi-asserted-by":"publisher","first-page":"130","DOI":"10.2174\/187221312800166859","volume":"6","author":"A Rossi","year":"2012","unstructured":"Rossi A, Cantisani C, Melis L, Iorio A, Scali E, Calvieri S. Minoxidil use in dermatology, side effects and recent patents. Recent Pat Inflamm Allergy Drug Discov. 2012;6(2):130\u20136.","journal-title":"Recent Pat Inflamm Allergy Drug Discov"},{"issue":"3","key":"3114_CR5","doi-asserted-by":"publisher","first-page":"189","DOI":"10.3109\/10799891003786234","volume":"30","author":"R Rastmanesh","year":"2010","unstructured":"Rastmanesh R. Alopecia and ocular alterations: a role for Minoxidil? J Recept Signal Transduct Res. 2010;30(3):189\u201392.","journal-title":"J Recept Signal Transduct Res"},{"issue":"8","key":"3114_CR6","first-page":"WD01","volume":"10","author":"H Aktas","year":"2016","unstructured":"Aktas H, Alan S, T\u00fcrkoglu EB, Sevik \u00d6. Could topical minoxidil cause non-arteritic anterior ischemic optic neuropathy? J Clin Diagn Res. 2016;10(8):WD01\u20132.","journal-title":"J Clin Diagn Res"},{"issue":"1","key":"3114_CR7","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1186\/s12886-020-01499-6","volume":"20","author":"R Venkatesh","year":"2020","unstructured":"Venkatesh R, Pereira A, Jain K, Yadav NK. Minoxidil induced central serous chorioretinopathy treated with oral eplerenone\u2014a case report. BMC Ophthalmol. 2020;20(1):219.","journal-title":"BMC Ophthalmol"},{"issue":"6","key":"3114_CR8","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1002\/jps.2600790605","volume":"79","author":"JJ Ferry","year":"1990","unstructured":"Ferry JJ, Shepard JH, Szpunar GJ. Relationship between contact time of applied dose and percutaneous absorption of minoxidil from a topical solution. J Pharm Sci. 1990;79(6):483\u20136.","journal-title":"J Pharm Sci"},{"issue":"1","key":"3114_CR9","doi-asserted-by":"publisher","first-page":"53","DOI":"10.3390\/ijms19010053","volume":"19","author":"S Yum","year":"2017","unstructured":"Yum S, Jeong S, Kim D, Lee S, Kim W, Yoo J-W, et\u00a0al. Minoxidil induction of VEGF is mediated by inhibition of HIF-prolyl hydroxylase. Int J Mol Sci. 2017;19(1):53.","journal-title":"Int J Mol Sci"},{"issue":"8","key":"3114_CR10","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1007\/BF02505237","volume":"288","author":"S Lachgar","year":"1996","unstructured":"Lachgar S, Charv\u00e9ron M, Bouhaddioui N, Neveux Y, Gall Y, Bonaf\u00e9 JL. Inhibitory effects of bFGF, VEGF and minoxidil on collagen synthesis by cultured hair dermal papilla cells. Arch Dermatol Res. 1996;288(8):469\u201373.","journal-title":"Arch Dermatol Res"},{"issue":"5","key":"3114_CR11","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1111\/1523-1747.ep12504905","volume":"95","author":"AE Buhl","year":"1990","unstructured":"Buhl AE, Waldon DJ, Baker CA, Johnson GA. Minoxidil sulfate is the active metabolite that stimulates hair follicles. J Invest Dermatol. 1990;95(5):553\u20137.","journal-title":"J Invest Dermatol"},{"key":"3114_CR12","unstructured":"http:\/\/patientsville.com\/minoxidil\/retinal-artery-occlusion.htm. Accessed 23 Feb 2020."},{"key":"3114_CR13","unstructured":"Adverse drug reaction probability scale (Naranjo) in drug induced liver injury. In: LiverTox: clinical and research information on drug-induced liver injury. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012. http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK548069\/. Accessed 15 July 2021."}],"container-title":["Journal of Medical Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13256-021-03114-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13256-021-03114-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13256-021-03114-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,7]],"date-time":"2021-10-07T23:47:23Z","timestamp":1633650443000},"score":1,"resource":{"primary":{"URL":"https:\/\/jmedicalcasereports.biomedcentral.com\/articles\/10.1186\/s13256-021-03114-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,8]]},"references-count":13,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["3114"],"URL":"https:\/\/doi.org\/10.1186\/s13256-021-03114-8","relation":{},"ISSN":["1752-1947"],"issn-type":[{"value":"1752-1947","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,8]]},"assertion":[{"value":"29 July 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 September 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 October 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional research committee (Narayana Nethralaya institutional review board\u2014C-2020-05-006) and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. The patient has provided his consent to be a part of the publication and also to use the images for publication purposes.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"This article does not contain any studies with animals performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Statement on human and animal rights"}},{"value":"Written informed consent was obtained from the patient for publication of this case report and any accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no conflict of interest.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"493"}}